ACVA ACV Auctions Inc. Insider Trading

CEO George Chamoun bought 24,272 shares of ACVA at $5.05 as stock down 70.7% from 52-week high

Chamoun purchased 24,272 shares at $5.05 on 2026-03-09, adding to his position of 2.95M shares in a company trading -70.7% from its 52-week high of $17.04. His recent buying pattern at ACVA shows mixed outcomes: his two prior buys at this ticker (2026-02-09 and 2026-01-12) both declined significantly 30 days after purchase (-31.5% and -18.3% respectively), though an earlier December 2025 buy posted a +10.9% 30-day return. His cross-ticker track record shows only 3 prior buys with an average 30-day return of -13.0%, suggesting open-market purchases have historically underperformed. ACVA remains unprofitable with negative $-24.5M net income in the latest quarter, and the stock has declined -31.5% over the past 30 days and -38.3% over 90 days, providing context for the severely depressed entry price relative to recent trading range.

Chief Sales Officer Michael Waterman buys 214,600 shares of ACVA at $4.66 after -37.4% 30-day decline

Michael Waterman, Chief Sales Officer, purchased 214,600 shares valued at $1,000,036.00 on 2026-02-26 at $4.66, increasing his holdings by +60.5% from 354,502 to 569,102 shares. This is a substantial open-market buy during sharp drawdown conditions: the stock is -71.3% from its 52-week high of $17.04 and down -37.4% in the 30-day window preceding the purchase. At the same-ticker level, Waterman's track record shows mixed outcomes: his 2 of 3 prior sells at ACVA were well-timed (90d returns were -21.5% and +4.9%, with the May 2025 sale of -21.5% showing the best foresight), but aggregate 30-day outcomes after his prior sells at ACVA averaged negative. The company remains unprofitable (net income of -$24,465,000.00 in the latest quarter) despite annual revenue growth of +19.2%, which establishes a fundamental context of operational losses against which to evaluate the purchase.

CEO George Chamoun buys 16,892 shares of ACVA at $7.30 amid -66.2% decline from 52-week high.

Chamoun purchased 16,892 shares at $7.30 on 2026-02-09, bringing his total holdings to 2,928,705 shares. This marks his second consecutive buy at ACVA within two months—he purchased shares again on 2026-01-12 and prior on 2025-12-15. The current price of $7.29 sits -66.2% from the 52-week high of $21.60 and reflects a 30-day decline of -17.0%, though the stock is up +32.8% over 90 days. At the same-ticker level, his prior buy on 2025-12-15 delivered a 30-day return of +10.9%, and two of his three prior ACVA trades proved well-timed at the 90-day mark. The company remains unprofitable (net income of $-24,465,000.00 for the latest quarter) but is growing revenue at +32.4% annually. Consecutive purchases during a sharp recent decline, combined with historical accuracy on this specific stock, warrant monitoring for conviction signals, though the steep valuation discount and near-term price volatility merit deeper scrutiny into the company's path to profitability.

CEO Chamoun George bought 14,286 shares of ACVA at $8.81 on 2026-01-12; stock now $8.74, -60.7% from 52-week high.

Chamoun George, Chief Executive Officer of ACV Auctions Inc., purchased 14,286 shares at $8.81 on 2026-01-12, increasing his holdings to 2,598,383 shares. The purchase occurs at a price 60.7% below the 52-week high of $22.25, and the stock is currently trading at $8.74, just $0.07 below the transaction price. At the same ticker, George has a mixed record: 2 of 4 prior measurable trades (both sales) were well-timed at the 90-day mark, with significant declines following two June 2025 sales (-35.1% and -33.0% respectively), but earlier March 2025 sales showed minimal 90-day movement. His cross-ticker track record shows 1 prior buy against 19 prior sells with a 47.37% well-timed rate—a below-average 90-day timing record. The company reported $199.6M in quarterly revenue with +32.4% annual growth, but posted a net loss of $24.5M, indicating continued unprofitability despite top-line expansion.

ACVA CEO Chamoun George purchased 31,172 shares at $7.97 on 2025-12-15 (total value $248,440.84); currently trading -65.3% from 52-week high at $7.72.

Chamoun George, CEO of ACV Auctions Inc., executed a $248.4K open-market share purchase at $7.97 on 2025-12-15, adding 31,172 shares to his holdings (now 2,618,714 shares total). The stock is currently trading at $7.72, down 65.3% from its 52-week high of $22.25, and the company remains unprofitable with a reported net loss of $-24,465,000.00 despite generating $199,561,000.00 in quarterly revenue (+32.4% annual growth). The timing is notable: his prior five trades at ACVA were all sells, with three of five demonstrating favorable 90-day outcomes (stock fell post-sale), suggesting a pattern of selling into strength. This buy occurs after significant price deterioration and follows a 30-day rebound of +22.5%, creating context for interpreting whether this represents opportunistic accumulation or a shift in the insider's recent selling posture at this ticker.

Director Castillo Kirsten bought 20,000 shares ($125.2K) at $6.26–$6.27; stock down -71.8% from 52-week high, cluster buy pattern with 2 other insiders.

Director Castillo Kirsten purchased 20,000 shares across 2 separate transactions totaling $125,250.00 at an average price of $6.26, doubling her shareholdings from 19,107 to 39,107 shares. The purchases occurred at prices substantially below the 52-week high of $23.17 and during a period of sharp price deterioration: the stock is down -71.8% from its 52-week peak, -23.8% over 30 days, and -42.5% over 90 days. Notably, 2 other insiders also bought within the past 14 days, forming a cluster buy pattern. The company is unprofitable on a full-year basis with net income of $-24,465,000.00, though it generated annual revenue growth of +32.4%, suggesting operational momentum despite near-term profitability challenges. This filing presents a pattern of insider accumulation in a materially depressed stock environment alongside concurrent purchases by peer insiders.

Director Brian Hirsch buys 80.6K shares of ACVA at $6.21; +421.7% holdings increase amid cluster pattern.

Director Brian Hirsch purchased 80,571 shares at $6.21 on 2025-11-14, increasing his total holdings from 19,107 shares to 99,678 shares—a +421.7% increase. This transaction occurs during a stock decline of -73.1% from the 52-week high of $23.17 and -46.7% over the past 90 days, yet the purchase happens at a price below the current level of $6.24. The buy aligns with a cluster pattern: 2 other insiders have also bought within the past 14 days, suggesting coordinated insider confidence at these depressed levels. Notably, Hirsch's own same-ticker history shows 5 prior sells with mixed timing outcomes (only 2 of 5 well-timed at 90-day mark), so his historical accuracy at this specific ticker is modest. The company posted revenue of $199,561,000.00 and a net loss of $-24,465,000.00 in the latest quarter, with an annual revenue growth of +32.4% but unprofitable full-year results, limiting conviction signals from fundamentals alone.

Director Goodman purchases 912,408 shares of ACVA at $5.61 (total $5.1M) amid -76.3% decline from 52-week high.

Director Robert P. Goodman acquired 912,408 shares at $5.61 per share for a total value of $5,118,608.88, establishing an initial position in ACV Auctions Inc. stock. The purchase occurs at a price substantially depressed relative to historical recent range: the stock has declined 76.3% from its 52-week high of $23.17 and has fallen 35.3% over the past 30 days and 51.4% over 90 days. Importantly, the company's most recent fundamentals are mixed—annual revenue growth of 32.4% demonstrates market-expansion momentum, but the company is unprofitable with a net loss of $24,465,000.00 against quarterly revenue of $199,561,000.00, and the full fiscal year also closed with negative net income. The scale of this insider acquisition—representing a new director position with no prior shareholding—warrants monitoring to understand whether this signals management's view of valuation, commitment to turnaround, or other board-level context not captured in price or earnings metrics alone.

CEO Chamoun George sold 350,000 shares (350.0K shares) at $16.81 avg for $5.9M on June 10-11, reducing stake by 11.6%

Chamoun George executed 2 separate sales totaling 350,000 shares for $5,882,560.18, reducing his holdings from 3,004,367 to 2,654,367 shares post-transaction. The company is currently unprofitable with net income of $-14,817,000.00 against quarterly revenue of $182,697,000.00, despite strong annual revenue growth of +32.4%. The stock has declined 29.1% from its 52-week high of $23.17 to the current price of $16.42, though it is up 14.7% over 90 days. His prior ACVA sales show a 2-of-3 well-timed rate at the 90-day mark, with the December 2024 sales preceding declines of -36.4% and -39.5%, suggesting he has historically exited ahead of material price weakness at this ticker.

Chief Sales Officer Michael Waterman sells 223,330 shares of ACVA at $17.00; stock down 26.9% from 52-week high and unprofitable

Waterman, the Chief Sales Officer, sold 223,330 shares (35.5% of his pre-transaction holdings) for $3,796,610.00 on 2025-05-13 at $17.00 per share, leaving him with 405,636 shares. The sale occurs when ACVA trades at $16.93, down 26.9% from its 52-week high of $23.17, and the company reported a net loss of $14.8M on $182.7M revenue in its latest quarter despite strong 32.4% annual revenue growth. His prior two sales at ACVA were poorly timed by the 90-day standard: the September 2024 sale saw stock rise +4.9% within 90 days, and the March 2025 sale shows -7.8% over 30 days with 90-day outcome not yet measurable. Cross-ticker, his timing record shows a 0.00% well-timed rate on 2 prior sells with an average 90-day return of +4.9%, indicating consistent poor timing of market exits. This sale represents a material reduction in his ACVA exposure at a depressed valuation relative to 52-week levels, though his demonstrated inability to time exits and the company's ongoing unprofitability suggest investors should monitor whether subsequent price action validates this decision.